“…ADSCs have the capacity to differentiate into adipocytes, chondrocytes, osteoblasts, or myoblasts under appropriate stimuli and culture conditions. In contrast to bone marrow-derived mesenchymal stem cells, ADSCs provide (1) greater availability (up to 10% of nucleated cells from ADSCs 4,52 vs 0.001% to 0.01% of bone marrow-derived mesenchymal stem cells 42 ), (2) less donor site morbidity, and (3) rapid expansion and high proliferation potential 23 for various applications in the field of tissue engineering and regenerative medicine. 39,53 In addition, the intra-articular injection of ADSCs has been found to be a safe therapeutic alternative with no significant complications.…”